Form 4 for ASND Ascendis Pharma A/S
Accepted 2026-09-09 17:04:07 ET · period of report 2026-09-08 · accession 0001610717-26-000409 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-09 17:04 | 2026-09-08 | ASND | Bodenhoff Mads | SVP, PAO | M - OptEx | $110.00 | +3,000 | 3,000 | New | +$330.0K |
| D | 2026-09-09 17:04 | 2026-09-08 | ASND | Bodenhoff Mads | SVP, PAO | S - Sale+OE | $270.19 | -3,000 | 0 | -100% | -$810.6K |
| D | 2026-09-09 17:04 | 2026-09-08 | ASND | Bodenhoff Mads | SVP, PAO | M - OptEx | $0.00 | -3,000 | 687 | -81% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-09-08 | M | A | 3,000 | $110.00 | 3,000 | D | — | — | |
| 2 | Common | Ordinary Shares | 2026-09-08 | S | D | 3,000 | $270.19 | 0 | D | — | — | |
| 3 | Derivative | Warrants | 2026-09-08 | M | D | 3,000 | $0.00 | 687 | D | $110.00 · — to 2032-10-11 | 3,000 Ordinary Shares | (F1) The warrants vested 25% on October 11, 2023 and thereafter in 36 equal monthly installments. |